APA (7th ed.) Citation

Borroni, R. G., Malagoli, P., Gargiulo, L., Valenti, M., Pavia, G., Facheris, P., . . . Costanzo, A. (2021). Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Society for Publication of Acta Dermato-Venereologica.

Chicago Style (17th ed.) Citation

Borroni, Riccardo G., et al. Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Society for Publication of Acta Dermato-Venereologica, 2021.

MLA (8th ed.) Citation

Borroni, Riccardo G., et al. Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Society for Publication of Acta Dermato-Venereologica, 2021.